Checkpoint Therapeutics, Inc. (CKPT)

Checkpoint Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	0.1	0.19	0.27	1.07	1.71
Revenue Growth (YoY)	-46.35%	-28.36%	-74.93%	-37.41%	-51.28%
Gross Profit	0.1	0.19	0.27	1.07	1.71
Selling, General & Admin	8.69	8.7	8.54	7.92	7.23
Research & Development	43.57	49.83	48.45	16.35	19.33
Operating Expenses	52.25	58.53	56.99	24.27	26.56
Operating Income	-52.15	-58.33	-56.72	-23.2	-24.85
Other Expense / Income	-0.3	4.29	-0.05	-0.12	-0.14
Pretax Income	-51.85	-62.62	-56.67	-23.08	-24.71
Net Income	-51.85	-62.62	-56.67	-23.08	-24.71
Shares Outstanding (Basic)	19	9	8	6	4
Shares Outstanding (Diluted)	19	9	8	6	4
Shares Change	112.13%	16.21%	36.18%	58.14%	23.64%
EPS (Basic)	-3.17	-7.09	-7.45	-4.10	-7.00
EPS (Diluted)	-3.17	-7.09	-7.45	-4.10	-7.00
Free Cash Flow	-47.59	-57.55	-26.31	-16.55	-21.37
Free Cash Flow Per Share	-2.54	-6.51	-3.46	-2.96	-6.05
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-50629.13%	-30381.77%	-21165.30%	-2170.35%	-1454.92%
Profit Margin	-50336.89%	-32616.67%	-21145.52%	-2159.12%	-1446.96%
Free Cash Flow Margin	-46203.88%	-29976.04%	-9815.67%	-1548.27%	-1251.35%
EBITDA	-51.85	-62.62	-56.67	-23.08	-24.71
EBITDA Margin	-50336.89%	-32616.67%	-21145.52%	-2159.12%	-1446.96%
EBIT	-51.85	-62.62	-56.67	-23.08	-24.71
EBIT Margin	-50336.89%	-32616.67%	-21145.52%	-2159.12%	-1446.96%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).